Smithbridge Asset Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$539K Sell
84,542
-84,542
-50% -$588K 0.08% 126
2025
Q4
$1.19M Buy
169,084
+84,542
+100% +$510K 0.1% 98
2025
Q3
$465K Hold
84,542
0.07% 121
2025
Q2
$437K Hold
84,542
0.08% 102
2025
Q1
$563K Buy
+84,542
New +$643K 0.1% 103
2024
Q3
$592K Hold
84,542
0.1% 113
2024
Q2
$415K Hold
84,542
0.09% 118
2024
Q1
$522K Hold
84,542
0.11% 109
2023
Q4
$662K Hold
84,542
0.15% 103
2023
Q3
$581K Hold
84,542
0.14% 107
2023
Q2
$772K Sell
84,542
-61,653
-42% -$512K 0.18% 97
2023
Q1
$1.09M Hold
146,195
0.27% 78
2022
Q4
$722K Hold
146,195
0.19% 97
2022
Q3
$968K Buy
+146,195
New +$1.02M 0.4% 65

Other funds holding LFST

Smithbridge Asset Management's LFST Position: Q1 2026 in Review

Smithbridge Asset Management reduced its Lifestance Health (LFST) stake by 50% in Q1 2026, selling an estimated $588K and leaving 84,542 shares worth $539K. The position accounts for 0.08% of the portfolio, ranked #126.

Smithbridge Asset Management first reported a position in LFST in Q3 2022 and has held it in 14 quarters since. The position peaked at $1.19M in Q4 2025. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Smithbridge Asset Management held 84,542 shares of Lifestance Health worth $539K as of Q1 2026.
  • Smithbridge Asset Management sold 84,542 Lifestance Health shares in Q1 2026, an estimated $588K.
  • Lifestance Health made up 0.08% of Smithbridge Asset Management's portfolio in Q1 2026, its #126 holding.
  • Smithbridge Asset Management first reported a position in Lifestance Health in Q3 2022 and has held it in 14 quarters since.
  • Smithbridge Asset Management's Lifestance Health position peaked at $1.19M in Q4 2025.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Smithbridge Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.